GlycoMimetics
GLYC
$1.64
Share price
-4.09%
Change (1 day)
19.71%
Change (1 year)
Categories
GlycoMimetics (GLYC) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $6.65 M
According to GlycoMimetics 's latest financial reports the company's total liabilities are $6.65 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
GlycoMimetics - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $8.88 M | -30.31% |
| 2021-12-31 | $12.74 M | -12.8% |
| 2020-12-31 | $14.61 M | 6.13% |
| 2019-12-31 | $13.76 M | 46.87% |
| 2018-12-31 | $9.37 M | 5.55% |
| 2017-12-31 | $8.88 M | 25.32% |
| 2016-12-31 | $7.08 M | -11.31% |
| 2015-12-31 | $7.99 M | 23.68% |
| 2014-12-31 | $6.46 M | 171.9% |
| 2013-12-31 | $2.37 M | -59.67% |
| 2012-12-31 | $5.89 M | -71.19% |
| 2011-12-31 | $20.45 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 1,484,701.62% | 🇺🇸 USA |
 Pfizer PFE | $137.21 B | 2,062,319.87% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | 865,868.94% | 🇫🇷 France |
 Palatin Technologies PTN | $24.93 M | 274.86% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.39 B | 5,778.12% | 🇺🇸 USA |